Tasmanian Botanics C100 CBD Oil — Buy Now

Tasmanian Botanics C100 CBD Oil — Buy Now – Tasmanian Botanics C100 CBD Oil

Tasmanian Botanics C100 CBD Oil — Premium Value Pure CBD for Australian Medicinal Cannabis Patients

Tasmanian Botanics C100 CBD Oil stands as one of the most compelling value propositions in the Australian medicinal cannabis market, combining pharmaceutical-grade cannabidiol concentration with the clean agricultural heritage of Tasmania’s temperate growing environment. Patients who buy Tasmanian Botanics C100 CBD Oil are not simply purchasing a supplement. They are accessing a TGA-approved medicinal product manufactured to the same rigorous standards applied to conventional pharmaceutical preparations, with the full traceability and documentation that serious patients and prescribing clinicians rightly expect. The C100 designation refers to the cannabidiol concentration profile of this formulation, placing it firmly in the high-strength CBD category that experienced patients and those managing complex chronic presentations typically require.

Tasmania’s agricultural environment contributes meaningfully to the character of this product in ways that extend beyond marketing language. The island state’s cool temperate climate, clean air mass, low industrial pollution index, and strict agricultural biosecurity standards collectively create growing conditions that minimise pesticide dependency and heavy metal soil contamination risks. These environmental factors translate into starting plant material with a cleaner phytochemical baseline before extraction even begins, and that baseline quality is preserved through Little Green Pharma’s pharmaceutical manufacturing process, which applies Good Manufacturing Practice standards at every stage from cultivation through to the sealed final product. The Value Pure CBD positioning of the C100 reflects a deliberate formulation philosophy. Rather than blending multiple cannabinoids at competing concentrations, this product delivers cannabidiol as the primary active compound in a carrier oil base, allowing patients and their prescribing practitioners to build a precise, predictable dosing relationship without the variable interaction effects that broad or full spectrum formulations can introduce. This makes the C100 particularly well suited to patients who are titrating their CBD intake under medical supervision and need a consistent, single-variable product to work with across their treatment period.

Condition Metrics and Product Specifications

THC Percentage: The C100 formulation is produced as a CBD-dominant medicinal cannabis oil with THC content maintained at a level compliant with TGA scheduling requirements for CBD-dominant products. The THC concentration falls below the threshold that triggers impairment concerns for the vast majority of patients, making it appropriate for patients who require daytime functionality alongside their treatment protocol. Exact per-batch THC figures are documented in the certificate of analysis accompanying each product unit and are available for review prior to dispensing.

CBD Percentage: The C100 delivers cannabidiol as its primary active cannabinoid at a concentration formulated to provide meaningful therapeutic effect within standard dosing volumes. The high-strength CBD profile places this product in the category preferred by patients managing presentations that have not responded adequately to lower-concentration formulations. Per-millilitre CBD content is verified by independent third-party laboratory testing on every production batch. Terpene Profile: As a Value Pure CBD formulation, the C100 is processed to deliver a refined cannabidiol concentrate in carrier oil rather than a full botanical extract, meaning the terpene content is intentionally minimised compared to broad or full spectrum alternatives. This refinement is a deliberate product choice, not a quality shortfall. Patients who are sensitive to terpene compounds or who prefer the cleanest possible oil profile will find the C100 formulation particularly well matched to their needs.

Cultivar Lineage: The hemp cultivar used in the production of Tasmanian Botanics C100 CBD Oil is selected for its high inherent CBD expression and low THC genetic baseline, consistent with Little Green Pharma’s cultivation program on their licensed Tasmanian growing operations. Cultivar selection is managed at the agronomic level to ensure that the raw plant material entering the extraction process meets the cannabinoid ratio requirements of the finished formulation before any processing adjustment is applied.

Batch Testing: Every batch of C100  undergoes independent third-party laboratory analysis covering cannabinoid potency, residual solvent screening, pesticide residue testing, heavy metal analysis, and microbiological contamination screening. The resulting certificate of analysis is batch-specific and is matched to the product unit at the point of dispensing. Patients can request their batch certificate through their dispensing pharmacy or prescribing practitioner, providing complete visibility over the safety and potency profile of the specific unit they are consuming. Moisture Content: The extraction and formulation process applied to Tasmanian Botanics C100 CBD Oil produces a finished oil product rather than a botanical powder or resin, meaning moisture content in the conventional sense does not apply to this liquid formulation. Stability is instead governed by the carrier oil base, which is selected and tested for oxidative stability, and by the product’s storage requirements, which specify cool, dark conditions away from direct light and heat to maintain potency across the stated shelf life.

Trim Quality: The plant material used as the source biomass for C100 extraction is cultivated and harvested under controlled conditions on Little Green Pharma’s licensed Tasmanian operations. Input material quality is assessed prior to extraction to confirm cannabinoid content and the absence of contaminating material. Because this is a refined oil extract rather than a whole-plant product, the trim quality consideration translates into the purity and potency of the extracted cannabidiol rather than a visible product characteristic. Packaging Freshness Seal: Each bottle of Tasmanian Botanics C100 CBD Oil is sealed at the point of manufacture under pharmaceutical packaging standards with a tamper-evident freshness seal that provides patients with visible confirmation that the product has not been opened or compromised between production and receipt. The seal integrity is a TGA compliance requirement and a meaningful patient safety assurance. Do not accept or consume any unit where the tamper-evident seal has been broken or is absent.

Secure Dispensing Logistics and Our Fulfillment Guarantee

All orders of Tasmanian Botanics C100 CBD Oil are processed and dispatched in compliance with Australian regulations governing the transport of scheduled medicinal cannabis products. Pre-shipment quality checks are conducted on every order before dispatch, confirming that the correct product, correct batch, and intact tamper-evident seal are present and that the packaging is undamaged and fit for transit. This check is not a courtesy step. It is a clinical responsibility, and we treat it as such on every single order that leaves our facility. Shipments are sent via a tracked courier service with full declared-value insurance applied to each consignment. Delivery is completed on a signature-required basis, consistent with the regulatory requirements governing scheduled medicinal cannabis products in Australia and with our commitment to ensuring that every unit reaches the correct recipient in confirmed condition. Patients should ensure that an authorised adult is available at the delivery address during the expected delivery window to receive and sign for the consignment.

In the event that transit damage is identified on receipt, our damage claim process is initiated within twenty-four hours of patient notification. We maintain complete dispatch records, pre-shipment photographs, and carrier booking documentation for every order, providing the evidentiary foundation needed to resolve insurance claims efficiently and without unnecessary burden on the patient. Our obligation is clear: the product that left our facility sealed, tested, and TGA-compliant is the product you receive ready for use under your prescribing practitioner’s guidance. Patients wishing to explore the full range of medicinal cannabis formulations available through this store are encouraged to browse the complete concentrates, extracts, and inhalation and ingestion collection at https://littlegreenpharma.shop/product-category/concentrates-extracts-inhalation-ingestion/ where additional products are listed alongside the C100.

Frequently Asked Questions